Certified by Founder Lodge
Psylo
Australia - Sydney, NSW
START UP
1 Disclosed Funding Rounds $8,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, u
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 04 ,2024 | Seed | $8,000,000 |
Mystic Ventures
Focalpoint Partners
Palo Santo
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Avallon AI (YC X25) | $4,600,000 | (Nov 7, 2025)
Kaizen Labs | $12,000,000 | (Nov 7, 2025)
SiteLabs | $2,000,000 | (Nov 7, 2025)
Fintary | $10,000,000 | (Nov 7, 2025)
Inception | $50,000,000 | (Nov 7, 2025)
